Product Information
SODIUM POLYSTYRENE SULF POWDER is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.4713 per GM under NDC 11534016616. Its NADAC has been published 171 times since Aug 18, 2021.
FDA first approved this application on Nov 28, 2014. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the sodium polystyrene sulfonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4.1 meq/g
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534016616
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL; RECTAL
Effective Date
8/19/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA204071FDA Approved
11/28/2014
TE Code
AA
On Market Since
1/24/2017
Price Statistics
The NADAC for SODIUM POLYSTYRENE SULF POWDER has been published 171 times since Aug 18, 2021, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4713 per GM |
|---|---|
| All-time high | $0.7701 (Jul 13, 2022) |
| All-time low | $0.3110 (Jan 21, 2026) |
| 52-week high | $0.4713 |
| 52-week low | $0.3110 |
| Median price | $0.5292 |
| Average price | $0.5323 |
| Largest weekly change | -43.3% (Sep 17, 2025) |
| Weeks tracked | 171 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SODIUM POLYSTYRENE SULF POWDER?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM POLYSTYRENE SULF POWDER, manufactured by Sunrise Pharmaceutical Inc., is $0.4713 per GM (NDC 11534016616), effective Aug 19, 2026.
How has the price of SODIUM POLYSTYRENE SULF POWDER changed over time?
Over the history we have for it, the NADAC for SODIUM POLYSTYRENE SULF POWDER has declined 11.0%. It has been tracked across 171 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for SODIUM POLYSTYRENE SULF POWDER?
Since Aug 18, 2021, the NADAC for SODIUM POLYSTYRENE SULF POWDER has ranged from a low of $0.3110 (Jan 21, 2026) to a high of $0.7701 (Jul 13, 2022), with a median of $0.5292 per GM.
Are there cheaper alternatives to SODIUM POLYSTYRENE SULF POWDER?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SODIUM POLYSTYRENE SULF POWDER, is $0.0949 per GM — about 80% below SODIUM POLYSTYRENE SULF POWDER.
Who manufactures SODIUM POLYSTYRENE SULF POWDER?
SODIUM POLYSTYRENE SULF POWDER (NDC 11534016616) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.